سعر اولميسبيرونوفا 20/25مجم 30 قرص 2024

Olmespironova tablets (olmesartan 20 mg + hydrochlorothiazide 25 mg) by Andalous Pharma for hypertension; 30 tablets per pack.

• Treatment of hypertension, to lower blood pressure; not indicated for initial therapy.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=2%): nausea, hyperuricaemia, dizziness and upper respiratory infection.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component; anuria.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Do not co-administer aliskiren in patients with diabetes.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Fetal toxicity: drugs acting on the renin-angiotensin system during the second and third trimesters reduce fetal renal function and increase fetal and neonatal morbidity and death; discontinue as soon as pregnancy is detected.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Correct volume or salt depletion before starting (risk of symptomatic hypotension); monitor renal function and potassium in susceptible patients.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Observe for fluid or electrolyte imbalance; acute myopia and secondary angle-closure glaucoma; systemic lupus erythematosus (hydrochlorothiazide).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• LithiumIncreased serum lithium concentrations and toxicity; monitor lithium levels.DailyMed (U.S. National Library of Medicine)
• NSAIDs including COX-2 inhibitorsMay deteriorate renal function and attenuate the antihypertensive effect.DailyMed (U.S. National Library of Medicine)
• ColesevelamReduces olmesartan exposure; give olmesartan at least 4 hours before colesevelam.DailyMed (U.S. National Library of Medicine)

• Can cause fetal harm; discontinue as soon as possible when pregnancy is detected (RAS-acting component).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Olmesartan: Olmesartan medoxomil is a prodrug hydrolysed to olmesartan, which blocks angiotensin II at the AT1 receptor.
• Hydrochlorothiazide: Inhibits sodium reabsorption in the distal tubule, increasing sodium and water excretion.